Home Newsletters Cancer Stem Cell News BCL6 and the Notch Pathway: A Signaling Axis Leading to a Novel...

BCL6 and the Notch Pathway: A Signaling Axis Leading to a Novel Druggable Biotarget in Triple Negative Breast Cancer

0
Scientists investigated signaling cascades of B cell lymphoma 6 (BCL6) in the CSC compartment of triple negative breast cancers, and the mechanisms that govern its activity, mainly through Notch signaling.
[Cellular Oncology]
6445212 AAAAAAAA items 1 apa 0 default asc 1 173725 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Abstract
Exit mobile version